FDA nonclinical toxicology review (2023-2024) flagged DNA damage in pituitary cells and injection-site necrosis in animal studies, plus immunogenicity and impurity risks from compounded material, alongside GH/IGF-1-axis effects such as fluid retention, joint discomfort, flushing, and headache reported by users
[19] Blood samples from 22 of 41 MS patients (54%) had active HHV-6 infections, compared to 0 of 61 control patients
requires specialized formulation Community reports: Occasional anecdotal mentions but no systematic evaluation Subcutaneous (Injection) Subcutaneous injection (beneath the skin) is occasionally discussed: Advantage: Avoids digestive breakdown
\Cardiovascular Benefit: Potential improvements in blood pressure, lipids, and inflammation
Stimulant medications: High blood pressure, rapid heart rate, heart rhythm concerns, anxiety, and misuse risk